Exploring single-session therapy visits for mental health care
Implementation of Single Session Interventions in Integrated Behavioral Health: Increasing Access to Evidence-based Care
This study is testing whether short, one-time therapy sessions can help people with mild to moderate depression and anxiety feel better when they visit the Mayo Clinic for mental health care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06347822 on ClinicalTrials.gov |
What this trial studies
This research investigates the interest and effectiveness of single-session therapy visits for patients seeking mental health services at Mayo Clinic's Integrated Behavioral Health program. The study aims to determine if these brief therapy sessions can improve mental health outcomes for individuals with mild to moderate depression and anxiety. By focusing on patients already scheduled for consultations, the researchers hope to gather insights into the feasibility and potential benefits of this approach in integrated care settings.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for an Integrated Behavioral Health consultation at Mayo Clinic who can read and speak English and have mild to moderate symptoms of depression or anxiety.
Not a fit: Patients with severe mental health conditions, such as psychotic disorders or severe substance use disorders, will not benefit from this study.
Why it matters
Potential benefit: If successful, this could provide patients with a more accessible and efficient option for mental health care.
How similar studies have performed: While this approach is relatively novel, previous studies have indicated potential benefits of brief therapy sessions in mental health care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Being a patient currently scheduled for an IBH consultation session at Mayo Clinic Rochester.
* Able to read and speak English.
Exclusion Criteria:
* Individuals diagnosed with psychotic spectrum, Bipolar I and II, or severe substance use disorder and individuals with severe cognitive impairment per chart review will not be eligible and will not be contacted about the study. Individuals must score ≥ 5 on the PHQ-9 and/or GAD-7 but not \>14 on either measure (indicating mild to moderate depression and/or anxiety) and respond \< 2 to Item 9 of the PHQ-9 ("thoughts that you would be better off dead, or thoughts of hurting yourself in some way") to be eligible for the study.
* Patients who are ineligible will remain scheduled for a regular IBH therapy consultation as originally planned.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Anne Roche, PhD — Mayo Clinic
- Study coordinator: Anne I Roche, PhD
- Email: roche.anne@mayo.edu
- Phone: 507-284-0592
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.